AcquisitionOther
Roche Holdings, Inc. Poseida stockholders to receive up acquired Poseida Therapeutics, Inc.
Public deal record from 8-K. The source names the buyer and target, and terms are shown only when the filing or announcement discloses them.
Deal tape row
Roche Holdings, Inc. Poseida stockholders to receive up -> Poseida Therapeutics, Inc. · $13.00
Poseida stockholders to receive up to $13.00 per share in cash, comprised of $9.00 per share in cash at closing and a non-tradeable contingent value right (CVR) to receive up to an aggregate of $4.00 per share in cash; transaction represents total equity value
Open source record (SEC) ↗